China Biologic Starts Selling Human Immunoglobulin To Neighboring India, Scans Globe For New Markets
This article was originally published in PharmAsia News
Executive Summary
BEIJING - China Biologic Products has signed a unique deal to supply India with plasma-based biopharmaceuticals, and is scanning the global market for other potential importers, according to company executives
You may also be interested in...
Acquisitions Catapult China Biologic Into Leading Biopharma Outfit; Position It For Global Competition With U.S., EU Players
BEIJING - The chief executive officer of China Biologic Products Inc. said an aggressive acquisition strategy has helped transform the company into China's leading privately held provider of plasma-based biopharmaceuticals, and that the outfit is aiming to expand its geographical footprint across the globe
Acquisitions Catapult China Biologic Into Leading Biopharma Outfit; Position It For Global Competition With U.S., EU Players
BEIJING - The chief executive officer of China Biologic Products Inc. said an aggressive acquisition strategy has helped transform the company into China's leading privately held provider of plasma-based biopharmaceuticals, and that the outfit is aiming to expand its geographical footprint across the globe
China Biologic Renews GMP Certification Under Stiffer SFDA GMP Rules
SHANGHAI- China Biologic Products has renewed its GMP certification for its production facility in Taian City in compliance with China State FDA's new, strict GMP standards, which took effect in January